Valify Named Finalist in D CEO’s 2026 Excellence in Healthcare Awards

Recognition highlights Valify’s continued innovation in helping health systems manage their purchased services programs

FRISCO, Texas–(BUSINESS WIRE)–#healthcare–Valify, the leading purchased services technology platform for healthcare, has been named a finalist for Achievement in Innovation in D CEO’s 2026 Excellence in Healthcare Awards. This year’s finalists were selected from a competitive pool of over 200 nominations across the North Texas healthcare community.

1b7db012 b33b 4bb3 b449 3ef129e5625f
1b7db012 b33b 4bb3 b449 3ef129e5625f
Valify logo hor cmyk pos transparent
Valify logo hor cmyk pos transparent

The recognition follows a period of significant growth and product innovation for Valify, as the company expanded its platform with AI capabilities to help hospitals and health systems more quickly identify, prioritize and act on savings opportunities across purchased services.

Purchased services remain one of the most overlooked opportunities for cost optimization in healthcare. Valify combines comprehensive spend data, benchmarking, sourcing expertise and execution support to help hospitals and health systems identify and capture 10-30% savings on average across under-managed categories.

“We’re honored to be recognized by D CEO alongside so many healthcare leaders across North Texas,” said Les Popiolek, CEO of Valify. “Health systems are under significant pressure to reduce costs, but purchased services remain an often-overlooked source of savings. We continue to enhance our technology to help health systems uncover opportunities and translate them into tangible outcomes.”

As the only healthcare purchased services company that collects data from members of every major group purchasing organization (GPO), the company provides a broader view of the market to uncover pricing variability, strengthen benchmarking, and give health systems greater confidence in savings decisions. Valify’s platform is powered by more than $1.3 trillion in spend data, normalized across a proprietary schema of over 1,400 categories.

Over the past year, Valify has expanded its platform with new capabilities, making it easier for health systems to transform complex purchased services data into actionable opportunities. These include Valify-defined Insights, Indicators, and Indexes to help organizations identify and prioritize high-impact savings opportunities. Initiatives provides tools to manage those opportunities through execution, and Valify AI Chat, launched earlier this year, gives teams a new way to explore and act on complex spend data using conversational, context-aware AI.

D CEO’s Excellence in Healthcare Awards recognize the top healthcare executives, practitioners, organizations and innovators making an impact in North Texas. The 2026 winners will be announced at an event in Dallas hosted by D CEO on Dec. 10.

For more information on how healthcare providers can benefit from Valify as their complete purchased services partner, please visit www.getvalify.com.

About Valify

Valify helps healthcare organizations optimize purchased services and indirect spend through a combination of technology, advisory expertise, and supplier partnerships. Our technology platform provides enterprise-wide spend visibility, benchmarking, market intelligence, and sourcing insights that help organizations identify opportunities and make informed decisions. Complementing these capabilities, Valify Advisory Services delivers strategic consulting and hands-on support to accelerate savings, improve performance, and drive sustainable results. Organizations also gain access to the Valify Preferred Supplier Network (PSN), offering no-cost membership, hundreds of pre-negotiated supplier agreements, competitive pricing, and flexible contract options across a broad range of categories. Together, Valify’s integrated approach helps healthcare organizations reduce costs, improve efficiency, and maximize value. Learn more at www.getvalify.com.

Contacts

Angel May

[email protected]
615.821.6844

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.